Biogen, UCB reportedly showing interest in Acorda acquisition; Kite Pharma and Pfizer to develop combo lymphoma therapy; hospitals to form generics nonprofit
Five things for pharma marketers to know: Tuesday, January 9, 2018
Teva diminishes debt with job cuts and sale; FDA to study whether consumers can detect misleading ads; AbbVie, Roche present positive Phase-III data at ASH
Five things for pharma marketers to know: Monday, December 11, 2017
Pfizer’s Viagra generic to sell for half the price; GSK seeks oncology deals; Ionis’ experimental Huntington’s drug tackles toxic protein for the first time
Five things for pharma marketers to know: Monday, November 27, 2017
AstraZeneca sales fall on generic competition; Anthem broadens access for Duchenne muscular dystrophy drug; researchers are developing new biopsy techniques